MetaVia
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MetaVia and other ETFs, options, and stocks.About MTVA
MetaVia, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing multi-modal disease-modifying therapies. Its pipeline includes ANA001, a proprietary oral niclosamide formulation, Gemcabene, which is assessed as an acute indication for COVID-19, NB-01, a treatment for painful diabetic neuropathy, and NB-02, which has the potential to treat the symptoms of cognitive impairment and modify the progression of neurodegenerative diseases.
MTVA Key Statistics
Stock Snapshot
With a market cap of 9.95M, MetaVia(MTVA) trades at $1.53. The stock has a price-to-earnings ratio of -0.37.
As of 2026-08-17, MetaVia(MTVA) stock has fluctuated between $1.43 and $1.52. The current price stands at $1.53, placing the stock +6.8% above today's low and +0.5% off the high.
MetaVia(MTVA) shares are trading with a volume of 69.06K, against a daily average of 84.32K.
In the last year, MetaVia(MTVA) shares hit a 52-week high of $19.03 and a 52-week low of $0.97.
In the last year, MetaVia(MTVA) shares hit a 52-week high of $19.03 and a 52-week low of $0.97.
MTVA News
MetaVia, the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Andrew Fein from H.C. Wainwright maintained a Buy rating on the st...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.